The low P/S ratio of Sutro Biopharma is attributed to its in...

The low P/S ratio of Sutro Biopharma is attributed to its inferior revenue outlook and shareholders' pessimism about the company's future growth. The company's share price is unlikely to rise significantly in the near future due to these circumstances.